Scalper1 News
Medical device stocks were moving Wednesday as three high-rated players all released preliminary Q4 numbers at the JPMorgan Healthcare Conference. Zeltiq Aesthetics (ZLTQ), a startup that sells a system for whittling down fat bulges, said late Tuesday that its Q4 sales were about $51 million to $52 million, up 44% from the year-earlier quarter and topping analysts’ consensus of $49.6 million. The company forecast 2015 sales of around $230 million, Scalper1 News
Scalper1 News